QCM
SNDX icon

Quantinno Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Quantinno Capital Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$665K Buy
30,440
+7,864
+35% +$164K ﹤0.01% 2827
2026
Q1 		$527K Buy
22,576
+2,237
+11% +$48.6K ﹤0.01% 2677
2025
Q4 		$427K Buy
+20,339
New +$355K ﹤0.01% 2574

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Quantinno Capital Management's SNDX Position: Q2 2026 in Review

Quantinno Capital Management increased its Syndax Pharmaceuticals (SNDX) stake by 35% in Q2 2026, buying an estimated $164K and bringing the position to 30,440 shares worth $665K. The position accounts for ﹤0.01% of the portfolio, ranked #2827.

Quantinno Capital Management first reported a position in SNDX in Q4 2025 and has held it in 3 quarters since. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Quantinno Capital Management held 30,440 shares of Syndax Pharmaceuticals worth $665K as of Q2 2026.
  • Quantinno Capital Management bought 7,864 Syndax Pharmaceuticals shares in Q2 2026, an estimated $164K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2827 holding.
  • Quantinno Capital Management first reported a position in Syndax Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.